Quick Answer
Scinai Immunotherapeutics Ltd. reported Earnings Per Share Diluted of $0.00 per share for the year ending 2023.
- Scinai Immunotherapeutics Ltd. showed a decrease of -60.0% in Earnings Per Share Diluted from 2022 to 2023.
- This data is from Scinai Immunotherapeutics Ltd.'s annual report (Form 10-K), filed with the SEC on May 7, 2025.
- XBRL data for this metric is available from 2021 to 2023 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2021 to 2023), Scinai Immunotherapeutics Ltd.'s Earnings Per Share Diluted has grown by 120.0%.
- Historical annual values: Fiscal year 2023: $0.00 per share | Fiscal year 2022: $0.01 per share | Fiscal year 2021: $0.02 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: